Syndax Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-5.53-7.89-15.36-50.36
Price/Sales ratio
7.033.412.181.57
Earnings per Share (EPS)
$-2.87$-2.01$-1.03$-0.31

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.80-8.64-2.35-3.02-1.52-4.78-12.5745.72-10.75-7.26-6.84-4.78
Price/Sales ratio
N/A332.4985.9287.2574.42176.47605.608.15N/AN/AN/A176.47
Price/Book Value ratio
-20.143.121.241.762.128.473.642.793.302.742.182.12
Price/Cash Flow ratio
-8.00-85.86-2.98-3.88-1.64-5.28-12.8939.12-11.56-9.46-7.64-5.28
Price/Free Cash Flow ratio
-7.99-84.16-2.95-3.87-1.64-5.28-12.8939.29-11.54-9.46-7.64-5.28
Price/Earnings Growth ratio
-0.340.26-0.010.65-2.210.123.30-0.350.01-0.280.01-2.21
Dividend Yield
N/AN/A2.47%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A100%100%100%100%100%100%99.67%N/AN/AN/A100%
Operating Profit Margin
N/A-3271.61%-3587.37%-2938.99%-5001.71%-3792.94%-4708.17%18.76%N/AN/AN/A-5001.71%
Pretax Profit Margin
N/A-3846.73%-3645.24%-2884.34%-4875.47%-3694.59%-4822.54%17.84%N/AN/AN/A-4875.47%
Net Profit Margin
N/A-3846.73%-3645.24%-2884.34%-4875.47%-3688.53%-4816.67%17.84%N/AN/AN/A-4875.47%
Effective Tax Rate
7.56%-6.37%0.20%0.12%-2.58%0.16%0.12%-0.17%3.74%N/AN/A-2.58%
Return on Assets
-154.71%-26.82%-40.79%-44.32%-88.11%-88.08%-24.30%5.54%-28.90%-34.16%-30.03%-88.11%
Return On Equity
346.88%-36.16%-52.85%-58.28%-139.42%-177.07%-28.97%6.10%-30.75%-37.77%-38.73%-139.42%
Return on Capital Employed
-863.64%-24.11%-44.36%-51.03%-111.85%-127.41%-25.35%6.11%-32.41%-41.44%-32.41%-111.85%
Liquidity Ratios
Current Ratio
N/AN/A10.468.445.173.3915.83N/AN/AN/A16.855.17
Quick Ratio
1.1918.1010.238.535.103.3015.5521.3016.709.9916.485.10
Cash ratio
0.964.782.302.222.091.336.1010.732.555.082.552.09
Days of Sales Outstanding
N/A150.1991.5465.2760.8727.9142.101.12N/AN/AN/A27.91
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A6.12K-3.41KN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A6.12KN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/A4.53K3.49K302.98KN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A1.58KN/AN/AN/AN/A
Debt Ratios
Debt Ratio
1.08N/AN/AN/AN/AN/A0.060.04N/AN/A0.05N/A
Debt Equity Ratio
-2.42N/AN/AN/AN/AN/A0.070.04N/AN/A0.06N/A
Long-term Debt to Capitalization
4.32N/AN/AN/AN/AN/A0.060.04N/AN/AN/AN/A
Total Debt to Capitalization
1.69N/AN/AN/AN/AN/A0.070.04N/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-30.30N/AN/AN/A-48.37N/A
Cash Flow to Debt Ratio
-1.03N/AN/AN/AN/AN/A-3.541.46N/AN/AN/AN/A
Company Equity Multiplier
-2.241.341.291.311.582.011.191.101.061.101.062.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-3.87-28.81-22.47-45.17-33.36-46.970.20N/AN/AN/A-45.17
Free Cash Flow / Operating Cash Flow Ratio
1.001.021.001.001.00110.991.00111
Cash Flow Coverage Ratio
-1.03N/AN/AN/AN/AN/A-3.541.46N/AN/AN/AN/A
Short Term Coverage Ratio
-2.23N/AN/AN/AN/AN/A-31.18N/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/A-5.84%N/AN/AN/AN/AN/AN/AN/AN/AN/A